Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar jhbarr (64.12) Submitted: 7/29/2010 11:11:27 AM : Outperform Start Price: $4.83 ALTH Score: -83.22

Approval?

Featured Broker Partners


Advertisement